Duration of antibody responses after severe acute respiratory syndrome

被引：295

作者：

Wu, Li-Ping

Wang, Nai-Chang

Chang, Yi-Hua

Tian, Xiang-Yi

Na, Dan-Yu

Zhang, Li-Yuan

Zheng, Lei

Lan, Tao

Wang, Lin-Fa

Liang, Guo-Dong ^{[1
]}

机构：

[1] Shanxi Prov Ctr Dis Control & Prevent, Taiyuan, Peoples R China

[2] Shanxi Prov Peoples Hosp, Taiyuan, Peoples R China

[3] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia

[4] Australian Biosecurity Ctr Emerging Infect Dis, Geelong, Vic, Australia

[5] State Key Lab Infect Dis Control & Prevent, Beijing, Peoples R China

来源：

EMERGING INFECTIOUS DISEASES | 2007年 / 13卷 / 10期

关键词：

D O I：

10.3201/eid1310.070576

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Among 176 patients who had had severe acute respiratory syndrome (SARS), SARS-specific antibodies were maintained for an average of 2 years, and significant reduction of immunoglobulin G-positive percentage and titers occurred in the third year. Thus, SARS patients might be susceptible to reinfection >= 3 years after initial exposure.

引用

页码：1562 / 1564

页数：3

共 15 条

[1] Longitudinal analysis of severe acute respiratory syndrome (SARS) coronavirus-specific antibody in SARS patients[J]. Chang, SC;Wang, JT;Huang, LM;Chen, YC;Fang, CT;Sheng, WH;Wang, JL;Yu, CJ;Yang, PC. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2005(12)
[2] Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China[J]. Guan, Y;Zheng, BJ;He, YQ;Liu, XL;Zhuang, ZX;Cheung, CL;Luo, SW;Li, PH;Zhang, LJ;Guan, YJ;Butt, KM;Wong, KL;Chan, KW;Lim, W;Shortridge, KF;Yuen, KY;Peiris, JSM;Poon, LLM. SCIENCE, 2003(5643)
[3] Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein[J]. He, Yuxian;Li, Jingjing;Li, Wenhui;Lustigman, Sara;Farzan, Michael;Jiang, Shibo. JOURNAL OF IMMUNOLOGY, 2006(10)
[4] SARS coronavirus: a new challenge for prevention and therapy[J]. Holmes, KV. JOURNAL OF CLINICAL INVESTIGATION, 2003(11)
[5] Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats[J]. Lau, SKP;Woo, PCY;Li, KSM;Huang, Y;Tsoi, HW;Wong, BHL;Wong, SSY;Leung, SY;Chan, KH;Yuen, KY. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005(39)
[6] Bats are natural reservoirs of SARS-like coronaviruses[J]. Li, WD;Shi, ZL;Yu, M;Ren, WZ;Smith, C;Epstein, JH;Wang, HZ;Crameri, G;Hu, ZH;Zhang, HJ;Zhang, JH;McEachern, J;Field, H;Daszak, P;Eaton, BT;Zhang, SY;Wang, LF. SCIENCE, 2005(5748)
[7] Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome[J]. Liu, W;Fontanet, A;Zhang, PH;Zhan, L;Xin, ZT;Baril, L;Tang, F;Lv, H;Cao, WC. JOURNAL OF INFECTIOUS DISEASES, 2006(06)
[8] Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance[J]. Mo, HY;Zeng, GQ;Ren, XL;Li, H;Ke, CW;Tan, YX;Cai, CD;Lai, KF;Chen, RC;Chan-Yeung, MR;Zhong, NS. RESPIROLOGY, 2006(01)
[9] Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection[J]. Nie, YC;Wang, GW;Shi, XL;Zhang, H;Qiu, Y;He, ZP;Wang, W;Lian, GW;Yin, XL;Du, LY;Ren, LL;Wang, JW;He, X;Li, TS;Deng, HK;Ding, MX. JOURNAL OF INFECTIOUS DISEASES, 2004(06)
[10] Severe acute respiratory syndrome[J]. Peiris, JSM;Guan, Y;Yuen, KY. NATURE MEDICINE, 2004(12)

← 1 2 →